4-aryloxy quinoline derivatives as 5-HT6 modulators

Details for Australian Patent Application No. 2006286654 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Kress, James M.; Repke, David Bruce; Harris, III Ralph New; Stabler, Russel Stephen

Agent Spruson & Ferguson

Pub. Number AU-A-2006286654

PCT Pub. Number WO2007/025798

Priority 60/702,764 27.07.05 US

Filing date 17 July 2006

Wipo publication date 8 March 2007

International Classifications

C07D 215/22 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/025798 Priority application(s): WO2007/025798

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286682-Test method for detecting deviations in geoobjects

2006286646-Pyrazolone derivatives as 11-beta HSD1 inhibitors